Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study
Titel:
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study
Auteur:
Gan, Lin Xie, Xiaoxin Fu, Yanhua Yang, Xiaoyan Ma, Shujing Kong, Linghong Song, Chunli Song, Yebing Ren, Tingting Long, Hai